Luma Group is excited to announce its investment in Arsenal Biosciences, Inc. today. ArsenalBio has boldly embraced the mission of pioneering the next evolution of cellular therapies. We look forward to supporting Arsenal's work in the space of cell therapy for solid tumors and contributing to the future of cancer care.
Luma Group
风险投资与私募股权管理人
New York，New York 1,051 位关注者
Luma Group is an investment firm focused on the intersection of technology driven life sciences and healthcare
关于我们
Luma Group is an investment firm focused on the greatest breakthrough scientific discoveries that leverage advanced computation and AI. Luma invests in discovering, developing and commercializing potentially high-caliber technologies to seek to improve human health and longevity. We aim to focus on the following areas in biotech: next generation therapeutics, AI/ML enabled drug discovery platforms, AI/ML technologies transforming early disease detection and patient care, and devices and tools with advanced data capture mechanisms and analysis capabilities. Luma is led by Partners Josh Fink, Dr. Themasap Khan, PhD, and Dr. Jamie Kasuboski, PhD, each with over a decade of biotech investing and operational experience. The Luma team is backed by an advisory network that includes former C-suite executives at Fortune 500 companies, seasoned executives with strong track records in building biotech companies and healthcare leaders. We seek to leverage the Firm’s strengths to invest in companies that have strong intellectual property protections, and which address large unmet medical needs. Our mission is to work closely with portfolio companies to help them focus on addressing untapped markets and generating shareholder value.
- 网站
-
www.lumagroup.com
Luma Group的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 2-10 人
- 总部
- New York，New York
- 类型
- 私人持股
- 创立
- 2023
地点
-
主要
获取路线
US，New York，New York
Luma Group员工
动态
-
We are thrilled to formally announce Luma Group. We are wholly focused on discovering, developing and commercializing the greatest breakthrough scientific discoveries that leverage advanced computation and AI. We seek to improve human health and longevity. Luma is led by Partners Josh Fink, Themasap Khan, PhD, and James Kasuboski, PhD. The Luma team is backed by an advisory network that includes former C-suite executives at Fortune 500 companies, seasoned biotech executives and healthcare leaders. For more information and to access our thought leadership pieces and podcast, please visit lumagroup.com or reach out to [email protected].